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Abstract
Background: Escherichia coli occurs naturally in the human gut; however, certain strains that can cause infections,
are becoming resistant to antibiotics. Multidrug-resistant E. coli that produce extended-spectrum b lactamases
(ESBLs), such as the CTX-M enzymes, have emerged within the community setting as an important cause of urinary
tract infections (UTIs) and bloodstream infections may be associated with these community-onsets. This is the first
report testing the antibiotic resistance-modifying activity of nineteen Jordanian plants against multidrug-resistant E.
coli.
Methods: The susceptibility of bacterial isolates to antibiotics was tested by determining their minimum inhibitory
concentrations (MICs) using a broth microdilution method. Nineteen Jordanian plant extracts (Capparis spinosa L.,
Artemisia herba-alba Asso, Echinops polyceras Boiss., Gundelia tournefortii L, Varthemia iphionoides Boiss. & Blanche,
Eruca sativa Mill., Euphorbia macroclada L., Hypericum trequetrifolium Turra, Achillea santolina L., Mentha longifolia
Host, Origanum syriacum L., Phlomis brachydo(Boiss.) Zohary, Teucrium polium L., Anagyris foetida L., Trigonella
foenum-graecum L., Thea sinensis L., Hibiscus sabdariffa L., Lepidium sativum L., Pimpinella anisum L.) were combined
with antibiotics, from different classes, and the inhibitory effect of the combinations was estimated.
Results: Methanolic extracts of the plant materials enhanced the inhibitory effects of chloramphenicol, neomycin,
doxycycline, cephalexin and nalidixic acid against both the standard strain and to a lesser extent the resistant strain
of E. coli. Two edible plant extracts (Gundelia tournefortii L. and Pimpinella anisum L.) generally enhanced activity
against resistant strain. Some of the plant extracts like Origanum syriacum L.(Labiateae), Trigonella foenum- graecum
L.(Leguminosae), Euphorbia macroclada (Euphorbiaceae) and Hibiscus sabdariffa (Malvaceae) did not enhance the
activity of amoxicillin against both standard and resistant E. coli. On the other hand combinations of amoxicillin
with other plant extracts used showed variable effect between standard and resistant strains. Plant extracts like
Anagyris foetida (Leguminosae) and Lepidium sativum (Umbelliferae) reduced the activity of amoxicillin against the
standard strain but enhanced the activity against resistant strains. Three edible plants; Gundelia tournefortii L.
(Compositae) Eruca sativa Mill. (Cruciferae), and Origanum syriacum L. (Labiateae), enhanced activity of
clarithromycin against the resistant E. coli strain.
Conclusion: This study probably suggests possibility of concurrent use of these antibiotics and plant extracts in
treating infections caused by E. coli or at least the concomitant administration may not impair the antimicrobial
activity of these antibiotics.
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E. coli occurs naturally in the human gut; however, cer-
tain strains that can lead to infections are becoming
resistant to antibiotics. From the late 1990s, multidrug-
resistant Enterobacteriaceae (mostly Escherichia coli)
that produce extended-spectrum b lactamases (ESBLs),
such as the CTX-M enzymes, have emerged within the
community setting as an important cause of urinary
tract infections (UTIs) [1]. Recent reports have also
described ESBL-producing E. coli as a cause of blood-
stream infections associated with these community-
onsets of UTI [2]. Such development of drug resistance
in human pathogens against commonly used antibiotics
has necessitated a search for new antimicrobial sub-
stances, chemotherapeutic agents, and agrochemicals
that combine antimicrobial efficacy with low toxicity,
and minor environmental impact.
Natural products offer an untold diversity of chemical
structures. These natural compounds often serve as lead
molecules whose activities can be enhanced by manipu-
lation through combinations with chemicals and by syn-
thetic chemistry [3,4].
An important source of natural products is plants
which are rich in a wide variety of secondary metabo-
lites, such as tannins, terpenoids, alkaloids, and flavo-
noids. These metabolites have been found in vitro to
have antimicrobial properties [5-14]. Interest in medic-
inal plants has increased in recent years. This interest
has lead to the discovery of new biologically-active
molecules by the pharmaceutical industry and the adop-
tion of crude extracts of plants for self-medication by
the general public [3,4].
Many plants have been evaluated not only for their
inherent antimicrobial activity, but also for their action
as a resistance-modifying agent [15-18]. The enhance-
ment of antibiotic activity or the reversal of antibiotic
resistance by natural or synthetic non-conventional anti-
biotics has lead to the classification of these compounds
as modifiers of antibiotic activity.
In this study we screened nineteen Jordanian plants,
known to have antimicrobial activity in folk medicine
[19-23], for their possible effect as modifiers of antibio-
tic activity against bacteria. Some of them are edible and
considered safe. In general, these plants are used in folk
medicine in the treatment of skin diseases, gastrointest-
inal tract diseases and respiratory problems. The plants
used in this study and their properties are listed in
Table 1. Relative few studies have been carried out to
evaluate the antimicrobial properties of these plants.
Two strains of E. coli were used, a resistant strain,
which was isolated from a local hospitalized patient, and
a standard laboratory strain from the ATCC culture
collection.
Methods
Plant material
Plants were either collected from the field or purchased
from the local market (Table 1). The taxonomic identity
of the plants was confirmed by comparing collected
voucher specimens with those of known identity which
are located in the Herbarium of the Dept. of Biological
Science, Faculty of Science, University of Jordan in
Amman.
Preparation of plant extracts
Air dried and finely powdered plant materials were
extracted in a Soxhlet with two liters of methanol for 4
hrs, except for Capparis spinosa, which was extracted
for 10 hrs. Methanol is a semi polar solvent and is used
in extracting polar and apolar compounds
simultaneously.
Solvents were then evaporated under reduced pressure
and the extracts were conserved in tightly sealed glass
vials. Euphorbia macroclada latex was obtained by cut-
ting and squeezing the stem of the plant and examined
directly.
Determination of antimicrobial activity
Microorganisms
Ar e s i s t a n ts t r a i no fEscherichia coli was isolated from
hospitalized patients from the Jordan University Hospi-
tal and its identity confirmed by biochemical tests. A
standard laboratory strain of E. coli ATCC 8739 was
used as control.
Preparation of inoculum
Stock cultures were maintained at 4°C on slopes of
nutrient agar. Cultures for experiments were prepared
by transferring a sample from the stock cultures into
Mueller-Hinton broth (MHB) and incubating without
agitation for 24 hrs at 37°C. The cultures were diluted
with fresh Mueller-Hinton broth to achieve optical den-
sities corresponding to 2.0 × 10
6 colony forming units
(CFU/ml).
Antibiotics
Antibiotics used in this study were amoxicillin, (Merck),
chloramphenicol, (Fluka), neomycin, (Hikma Pharma-
ceutical Manufacture Co.), cephalexin, clarithromycin,
doxycycline, (Arab Pharmaceutical Manufacture Co) and
Nalidixic acid (Fluka).
Minimum inhibitory concentration (MIC) determination
for antibiotics
The MIC of the antibiotics was tested by the NCCLS
broth microdilution reference method [24] with some
modification. MIC tests were performed in 96 flat bot-
tom microtiter plates (TPP, Switzerland). Each test well
was filled with 100 μl nutrient broth. A sample (100 μl)
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Page 2 of 8Table 1 Uses and properties of ethnomedicinal plants used in this study.
Family Name Scientific
Name
(voucher
specimen)
%
yield
Part
used
Claimed Usage
1 Capparidaceae Capparis
spinosa L.
(Abbadi 99-20)
6 Roots Rheumatic pain Purgative and
anthelmentic
Internally: decoction Externally: paste of the root bark
of the plant is mixed with dough and applied on the
site of pain for 10-20 min
2 Compositae Artemisia
herba-alba
Asso.
(Abbadi 00-8)
4.5 Foliage Antidiabetic, Antispasmodic, pectoral,
antiarthritis
Infusion of 30 g in 1 L of water
3 Compositae Echinops
polyceras Boiss.
(Al-abd. 99-3)
9.1 Whole
plant
Wounds and warts pulverized powder of the plant is applied directly on
affected area
4 Compositae Gundelia
tournefortii L
(Abbadi 00-24)
6.7 Whole
plant
Edible like artichoke, antioxidant,
treatment of vitiligo, diuretic
Internally: Cooking, decoction Externally: a paste from
the plant prepared with Vaseline and applied
5 Compositae Varthemia
iphionoides
Boiss. &
Blanche
(VaI-M99)
8.8 Leaves
and
Stems
Women sterility, female fertilization,
eye infection, antispasmodic Anti-
inflammatory, diabetes.
Women delivery
Infusion, Vapor, Lotion, Vapors after burning with
Harmal
6 Cruciferae Eruca sativa
Mill.
(ES-M99)
11.2 Fruits Aphrodisiac Antispasmodic and for
renal colic
Decoction.
7 Euphorbiaceae Euphorbia
macroclada L.
(Al-abd. 98-11)
0.8 Latex Urticaria, warts One drop of stem sap is applied directly to affected
areas only
8 Euphorbiaceae Euphorbia
macroclada L.
(Al-abd. 98-1)
6.6 whole
plant
Urticaria, warts Decoction or pulverized powder of the plant is applied
directly on affected area
9 Gittiferae Hypericum
trequetrifolium
Turra
(Abbadi 99-23)
5.5 Arial
parts
Toxic Antidepressant in cases of
mania
Not used medicinally
10 Labiateae Achillea
santolina L.
(AS-M99)
7.9 Aerial
Parts
Carminative, Depurative,
Stomachaches, antispasmodic and
diabetes
Infusion and Decoction are prepared in water and
taken orally 3 times daily
11 Labiateae Mentha
longifolia Host
(ML-99)
10.6 Leaves Constipation, fever, common cold,
general weakness
Infusion of the plant is made with water or tea.
12 Labiateae Origanum
syriacum L.
(Majorana
syriaca (L.) Raf.
(Abbadi 00-19)
9.6 Leaves Carminative, pectoral, antitussive,
aperative, antistomach ache,
Carminative.
Infusion
13 Labiateae Phlomis
brachydon
(Boiss.) Zohary
(Al-Abd. 99-4)
3.6 Whole
plant
Stomach and intestine pain Decoction.
14 Labiateae Teucrium
polium L.
(Abbadi 99-5)
11.9 Aerial
parts
Spasm, flatulence, diabetes and
kidney stones
Infusion is prepared and taken orally three times a day.
15 Leguminosae Anagyris foetida
L.
(Al-abd. 99-2)
8.6 Leaves
& fruits
laxative, pectoral, purgative,
vermifuge
Decoction.
16 Leguminosae Trigonella
foenum-
graecum L.
(TF-M99)
6.3 Seeds Diabetes, sexual impotence, intestinal
pain, infant abdominal pain, skin
diseases
A decoction is prepared from the seeds and taken
orally 3 times daily. For infants a poultice is mad from
the seed and fixed in the site of pain. Externally the
decoction is used as a lotion.
17 Theaceae Thea sinensis L.
(TS-m99)
5.6 leaves Drink, externally anti-inflammatory Decoction.
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test well and mixed. A series of dilutions was then pre-
pared across the plate using a micropipette. The con-
centration ranges used to determine MICs were:
Amoxycillin 0.12-32 μg/ml, Chlormphenicol 0.5- 30 μg/
ml, Nalidixic acid 0.12-16 μg/ml, Cephalexin 0.5-42 μg/
ml, Neomycin 2-256 μg/ml, Doxycycline 0.5-128 μg/ml
and Clarithromycin 0.5-160 μg/ml. A 10 μla l i q u o to f
the standard laboratory strain of E. coli ATCC 8739 was
used to inoculate each microtiter plate well to achieve a
final inoculum size of 5 × 10
5 CFU/ml.
Positive growth controls (well with overnight culture,
nutrient broth and bacterial inoculum but without anti-
biotic) and negative controls (well with broth but with-
out inoculum) were also prepared and incubated at 37°
for 24 hrs.
Microbial growth in the test wells was detected as tur-
bidity, visualized by naked eyes, relative to the negative
and positive controls. MICs were calculated as follows:
MIC = C n +C (n+1)/2
Where
C n: Concentration at well number n, where no tur-
bidity was observed.
C (n + 1): Concentration at well number (n + 1),
where turbidity was observed.
MIC determination was carried out in triplicate (in
same 96-well plate) and repeated twice for each bacteria
and each tested agent. MICs values are shown in Table 2.
Modification of antibiotic activity by plant extracts
Antibiotics were added to 18.5 ml molten nutrient agar
to give half their MIC concentrations (Table 2). Dried
plant extracts were dissolved in absolute ethanol to give
a stock solution of 8 mg/ml. To determine the effect of
the plant extract on the activity of the antibiotics, 0.5 ml
of the ethanolic solution of the plant extract and 1 ml of
the bacterial suspension was added to the nutrient agar
containing the antibiotic to give an inoculum size of 5 ×
10
3 CFU/ml cells and a final concentration of 200 μg/
ml of the plant extract in the nutrient gar. The medium
was mixed thoroughly, poured in a plate and then incu-
bated at 37°C for 24 hrs. The number of colonies on
each plate (N) was determined. At the same time, for
each combination control counts (N0) which were deter-
mined by adding an inoculum size of 5 × 10
3 CFU/ml to
molten nutrient agar containing 0.5 ml of ethanol and
incubating at 37°C for 24 hrs. The percentage growth
was then calculated by reference to the control count
(considered as 100% growth) as follows
% growth of bacteria = N 100/N0 ×
Where
N0 is the number of colonies on the control count of
the blank
N is the colony count after exposure to combinations
of the antibiotic and the plant extract
Control and test counts were determined twice for
each bacterial strain and for each combination of anti-
biotic and plant extract.
The percentage growth was determined twice for
each bacterial strain and for each combination of anti-
biotic and plant extract. The test count was always
referred to the control (100% growth) count done at
the same time. The average percentage is presented in
Tables 3 &4.
Preliminary experiments were carried out to confirm
that plant extracts at 200 μg/ml, the antibiotics at half
their MICs, and the 0.5 ml of ethanol did not inhibit
growth of the challenge inoculum. These experiments
were also repeated every time the modification of anti-
biotic activity by plant extracts was studied.
Table 1: Uses and properties of ethnomedicinal plants used in this study. (Continued)
18 Malvaceae Hibiscus
sabdariffa L.
(Abbadi 00-
180)
6.4 Calyx Drink, antihypertensive Decoction.
19 Umbelliferae Lepidium
sativum L.
(LS-M99)
3.8 Seeds.
Fresh
plant
General tonic Infusion. The fresh plant is added to salad or eaten as
green vegetable.
20 Umbelliferae Pimpinella
anisum L.
(PA-M99)
9.9 Fruit Antiflatulance and antispasmodic Infusion.
Table 2 Minimum inhibitory concentrations of the
antibiotics used in the study against standard laboratory
strain of Escherichia coli ATCC 8739
Antimicrobial agent MIC (μg/ml)
Amoxicillin 16
Chloramphenicol 25
Neomycin 64
Doxycycline 32
Clarithromycin 150
Cephalexin 32
Nalidixic acid 8
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Plants used in this study are mentioned in Table 1.
Some of these plants are edible used either as food or in
the folk medicine and are considered safe. The rest of
the plants are not commonly used by the laymen, but
are used by herbalists in folk medicine [19-23].
The bacteria used in this study were resistant and
standard strains of E. coli. In addition to being an essen-
tial component of the gut flora, E. coli is an etiologic
agent for both hospital and community-acquired infec-
tions in humans [2,25,26]. As with other bacterial patho-
gens, this bacterium can develop single and multidrug
resistance to several antimicrobial families; consequently,
antimicrobial treatment of invasive E. coli infections can
be challenging. The antibiotics used in this study were
chosen to represent different groups of antibiotics. Their
concentrations were chosen to be approximately half
their MIC (Table 2) to guarantee that the effect pro-
duced is due to the combination and not to the effect of
the antibiotic alone.
The effects of the plant extracts on the growth of the
antibiotics against the resistant and standard strains of E.
coli are shown in Tables 3 and 4. Samples of the plants
without combinations allowed 100% growth of the inocu-
lum at level of 200 μgm l
-1.M e t h a n o l i ce x t r a c t so ft h e
plant materials significantly enhanced the inhibitory
effects of chloramphenicol, neomycin, doxycycline,
cephalexin and nalidixic acid (Table 3 and 4) against
both the standard strain and to a lesser extent the resis-
tant strain of E. coli. The effects varied significantly
according to the antibiotic and the E. coli strain. The effi-
cacy of the combinations in enhancing the antibacterial
activity was generally greater against the standard strain
where for some combinations no growth was detected (e.
g. combinations of chloramphenicol, neomycin, doxycy-
cline, cephalexin and nalidixic acid with almost all plant
material used). On the other hand, plant materials
enhanced activity of these antibiotics to a slightly lesser
extent against the resistant strain (Table 3).
Some of the plant materials used in the study like
Origanum syriacum L. (Labiateae), Trigonella foenum-
graecum L.(Leguminosae), Euphorbia macroclada
(Euphorbiaceae) and Hibiscus sabdariffa (Malvaceae)
did not enhance the activity of amoxicillin against both
Table 3 Effect of each plant extract combined with various antibiotics on growth of resistant E. coli.
%Growth on Combination with antibiotic
a (± SE)
b
Family Plant
c Blank
d Amo* Chl* Neo* Doxy* Clarith* Ceph* Nal*
1 Capparidaceae Capparis spinosa L 100 68.5 ± 4.6 75.9 ± 5.0 70.2 ± 2.9 40.5 ± 6.6 100 ± 4.2 76.8 ± 9.1 59.5 ± 5.7
2 Compositae Artemisia herba-alba Asso. 100 85.9 ± 3.5 77.8 ± 2.5 50.1 ± 4.5 30.7 ± 8.3 65.9 ± 3.5 68.9 ± 4.9 77.9 ± 7.1
3 Compositae Echinops polyceras Boiss 100 75.5 ± 2.2 85.9 ± 4.7 85.2 ± 2.3 40.5 ± 6.4 70.9 ± 5.7 79.9 ± 4.8 60.9 ± 5.1
4 Compositae Gundelia tournefortii L 100 50.9 ± 8.8 60.9 ± 2.8 75 ± 3.7 30.5 ± 4.6 52.5 ± 5.1 80.8 ± 8.4 89 ± 4.2
5 Compositae Varthemia iphionoides Boiss &
Blanche
100 49 ± 4.9 60.1 ± 6.3 70.5 ± 5.4 64.0 ± 8.4 85.5 ± 6.2 60.9 ± 2.0 70.9 ± 2.4
6 Cruciferae Eruca sativa Mill. 100 70.9 ± 6.5 51.6 ± 8.6 88.9 ± 2.3 25.5 ± 7.5 70.5 ± 4.2 60.5 ± 3.2 84.6 ± 4.9
7 Euphorbiaceae Euphorbia macroclada L. (latex) 100 100.2 ±
1.7
80.8 ± 6.4 90.1 ± 8.4 45.7 ± 5.9 80.5 ± 8.1 72.5 ± 7.6 99.7 ± 8.1
8 Euphorbiaceae Euphorbia macroclada L. (plant) 100 120.1 ±
6.3
80.8 ± 2.5 68.9 ± 3.9 26.2 ± 8.3 65.9 ± 4.7 89.9 ± 7.6 103 ± 2.8
9 Gittiferae Hypericum androsaemum L 100 77.9 ± 1.5 55.9 ± 2.6 75.8 ± 3.5 6.5 ± 7.4 89.9 ± 5.5 67.8 ± 8.4 92.0 ± 3.9
10 Labiateae Achillea santolina L. 100 70.5 ± 3.6 75 ± 3.3 61 ± 2.6 25 ± 4.9 70.2 ± 2.5 65.4 ± 5.6 75 ± 4.6
11 Labiateae Mentha piperita L. 100 75.1 ± 2.5 64.9 ± 4.5 97.8 ± 2.2 25.5 ± 1.9 100 ± 3.5 90.6 ± 7.3 84.9 ± 2.5
12 Labiateae Origanum syriacum L. 100 100 ± 4.9 70.9 ± 7.5 70.2 ± 6.5 30.6 ± 7.3 60.5 ± 5.6 55.8 ± 4.5 85.9 ± 3.2
13 Labiateae Phlomis brachydon (Boiss.) Zohary 100 90.6 ± 2.4 100 ± 5.2 100 ± 4.6 30 ± 3.9 87.5 ± 6.2 60.1 ± 7.3 70.9 ± 5.1
14 Labiateae Teucrium polium L. 100 68.9 ± 5.8 77.9 ± 2.5 85.5 ± 3.8 40.5 ± 7.3 70.5 ± 4.9 80.5 ± 2.6 96.9 ± 3.8
15 Leguminosae Anagyris foetida L 100 69 ± 5.4 80.9 ± 4.6 90.6 ± 3.6 50.5 ± 5.4 89.9 ± 2.6 89.9 ± 4.2 99.9 ± 3.9
16 Leguminosae Trigonella foenum- graecum L. 100 100 ± 8.4 88.9 ± 5.9 100 ± 3.2 55.5 ± 2.6 100 ± 7.1 90.5 ± 7.6 92.7 ± 7.2
17 Theaceae Thea sinensis L. 100 85.9 ± 4.8 50.8 ± 6.1 70.7 ± 5.1 15.0 ± 2.5 75.8 ± 3.9 90 ± 4.5 104 ± 2.5
18 Malvaceae Hibiscus sabdariffa L 100 120 ± 4.1 82.8 ± 5.6 85.5 ± 5.5 40.5 ± 6.4 80.7 ± 5.0 89.9 ± 6.4 80.5 ± 8.4
19 Umbelliferae Lepidium sativum L. 100 50.9 ± 1.9 67.9 ± 7.9 89.9 ± 6.2 40.5 ± 3.7 50.9 ± 6.1 70.7 ± 4.7 90.1 ± 2.6
20 Umbelliferae Pimpinella anisum L. 100 90.6 ± 3.3 66.9 ± 4.3 77.6 ± 1.6 25.5 ± 5.2 60.5 ± 4.2 84.6 ± 8.3 89.9 ± 4.9
aAmoxicillin (Amo), Chloramphenicol (Chl), Neomycin(Neo), Doxycycline (Doxy), Clarithromycin (Clarith), Cephalexin (Ceph) and Nalidixic acid (Nal).
bSE standard error
cplant extracts concentrations was (200 μg/ml)
* Antibiotics concentrations were half the MICs (presented in Table 2)
d Blank containing the solvent with the nutrient agar and the bacteria (allowed full growth of the microorganism (100%).
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other hand combinations of amoxicillin with other plant
materials used showed variable effect between standard
and resistant strains. Plant material like Anagyris foetida
(Leguminosae) and Lepidium sativum (Umbelliferae)
reduced the activity of amoxicillin against the standard
strain however; they enhanced the activity against resis-
tant strains (Tables 3 &4).
Activity of cephalexin on the resistant strain was
enhanced when used in combination with all plant
materials (Table 3). The enhancement of the activity of
cephalexin was more pronounced against the standard
strain with all the plant materials used (Table 4). Of
note is the fact that cephalexin is one of the first gen-
eration cephalosporins which do not normally have
activity against E. coli. This might indicate that the plant
material allowed better penetration of the drug through
the outer layers to the cell wall, which is the target site
for this antibiotic. This might also indicate that the
plant material acts by another mechanism such as
blocking the inhibitory effect of the enzymes.
Combinations of clarithromycin with three edible
plants; Gundelia tournefortii L. (Compositae) Eruca
sativa Mill. (Cruciferae), and Origanum syriacum L.
(Labiateae), enhanced activity against the resistant E.
coli strain (Table 3). However, combinations of this anti-
biotic with the other plant materials used did not
enhance the inhibitory effect significantly against both
standard and resistant strains.
The main mechanisms of resistance to antibiotics used
in this study are active efflux and enzymatic inactivation
[27]. Several studies have been performed to identify
drugs interfering with these pumps, called resistance
modifying agents [28]. Plant products, as ethanol
extracts of Mentha arvensis, are known to affect the
efflux system of an E. coli multiresistant to aminoglyco-
sides, inhibiting these resistance mechanism [29]. This
strategy is named “herbal shotgun” or “Synergistic
multi-target effects” and refers to the use of herbals and
drugs in a multi targeted approach, due to the fact that
mono or multi-extract combinations affect not one but
several targets, cooperating in an agonistic-synergistic
way. This approach is not exclusive for extract combina-
tions, but combinations between single natural products
or extracts with chemosynthetic or antibiotics are possi-
ble too [30-32].
The observed variations in the activity of the combina-
tions on the two strains indicate structural changes in
Table 4 Effect of each plant extract combined with various antibiotics on growth of standard E. coli.
%Growth on Combination with antibiotic
a (± SE)
b
Family Plant
c Blank
d Amo* Chl* Neo* Doxy* Clarith* Ceph* Nal*
1 Capparidaceae Capparis spinosa L 100 95.5 ± 5.9 NG
d NG
d 4.0 ± 3.6 93.0 ± 6.1 NG
d NG
d
2 Compositae Artemisia herba-alba Asso. 100 92.7 ± 7.2 1 ± 4.9 NG
d NG
d 89.0 ± 4.1 NG
d NG
d
3 Compositae Echinops polyceras Boiss 100 104.6 ± 6.1 NG
d 1.1 ± 3.5 2.5 ± 3.8 80.7 ± 4.6 1.1 ± 4.1 NG
d
4 Compositae Gundelia tournefortii L 100 70.8 ± 3.9 1.1 ± 8.7 NG
d NG
d 90.9 ± 2.7 NG
d 1.1 ± 5.6
5 Compositae Varthemia iphionoides Boiss & Blanche 100 85.5 ± 8.6 NG
d 1.1 ± 5.4 NG
d 103.4 ± 4.0 NG
d NG
d
6 Cruciferae Eruca sativa Mill. 100 85.5 ± 4.2 1 ± 5.6 1.1 ± 9.4 1.1 ± 8.1 100 ± 5.9 1.1 ± 1.9 1.5 ± 2.5
7 Euphorbiaceae Euphorbia macroclada L. (latex) 100 110 ± 6.4 NG
d 1.5 ± 5.6 1.1 ± 6.9 100 ± 4.3 1.9 ± 3.4 1.5 ± 1.8
8 Euphorbiaceae Euphorbia macroclada L. (plant) 100 100.7 ± 5.9 NG
d NG
d NG
d 80.5 ± 7.3 NG
d 2.2 ± 3.8
9 Gittiferae Hypericum androsaemum L 100 90.7 ± 6.6 NG
d 1.1 ± 4.1 1.5 ± 2.8 80.5 ± 2.5 1.1 ± 7.2 NG
d
10 Labiateae Achillea santolina L. 100 80.8 ± 3.4 1.9 ± 2.8 NG
d NG
d 90.1 ± 2.4 NG
d 1.9 ± 1.8
11 Labiateae Mentha piperita L. 100 90.9 ± 8.7 NG
d 1.1 ± 9.4 NG
d 92.5 ± 8.4 NG
d NG
d
12 Labiateae Origanum syriacum L. 100 90.8 ± 2.9 NG
d NG
d 1.1 ± 5.6 80.9 ± 4.5 NG
d 1.1 ± 1.9
13 Labiateae Phlomis brachydon (Boiss.) Zohary 100 85.5 ± 5.6 1.1 ± 3.1 NG
d NG
d 88.5 ± 7.3 NG
d NG
d
14 Labiateae Teucrium polium L. 100 75.5 ± 9.6 NG
d NG
d NG
d 80.5 ± 7.3 NG
d NG
d
15 Leguminosae Anagyris foetida L 100 102 ± 4.8 1.5 ± 4.1 NG
d NG
d 100.5 ± 7.3 1.1 ± 3.2 NG
d
16 Leguminosae Trigonella foenum- graecum L. 100 105.9 ± 4.1 NG
d 1.5 ± 6.6 NG
d 86.0 ± 6.4 1.1 ± 3.1 NG
d
17 Theaceae Thea sinensis L. 100 100 ± 3.6 NG
d NG
d NG
d 92.3 ± 8.4 NG
d NG
d
18 Malvaceae Hibiscus sabdariffa L 100 100 ± 4.3 NG
d NG
d 5.5 ± 2.2 70.9 ± 1.1 1.5 ± 4.5 NG
d
19 Umbelliferae Lepidium sativum L. 100 100 ± 1.6 NG
d NG
d 1.1 ± 4.1 90.9 ± 2.3 1.1 ± 5.5 55.8 ± 3.2
20 Umbelliferae Pimpinella anisum L. 100 90 ± 2.5 NG
d NG
d 1.1 ± 9.4 75.5 ± 10.0 1.1 ± 1.8 NG
d
a Amoxicillin (Amo), Chloramphenicol (Chl), Neomycin(Neo), Doxycycline (Doxy), Clarithromycin (Clarith), Cephalexin (Ceph) and Nalidixic acid (Nal).
bSE standard error
c plant extracts concentrations was (200 μg/ml)
* Antibiotics concentrations were half the MICs (presented in Table 2)
c Blank containing the solvent with the nutrient agar and the bacteria (allowed full growth of the microorganism (100%)
d NG no detectable growth
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Page 6 of 8standard and resistant strains. The observed variations
in the effects when using different plants and plants
belonging to the same families suggests different struc-
ture and mechanism of action for the active substance
(s) in these plants (Table 3 and 4).
Conclusion
On the basis of the evidence obtained from this study
some general conclusions can be drawn regarding the
effect of the plant material on the activity of antibiotics
used. Different plants sometimes belong to the same
family, have different effects on the activity of antibiotics.
Neomycin, chloramphenicol, doxycycline and cephalexin
can be given advantageously with almost all the plant
materials mentioned earlier with few exceptions (e.g.
with Trigonella foenum-graecum), however, clinical trials
are required to support that. The activity of amoxicillin
and clarithromycin were the least enhanced by the pre-
sence of the plant material against Gram negative bac-
teria. Doxycycline activity was the most significantly
improved when combined with the plant material when
tested against both bacterial strains. Nalidixic acid activ-
ity was improved significantly when combined with all
plant materials and tested on standard strains. On the
other hand, its activity on the resistant strain was slightly
improved using the same combinations.
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